The human microbiome, consisting of trillions of microorganisms living in the body, has been linked to cancer development and treatment response. Studies have shown that certain gut bacteria can influence the efficacy of immunotherapy and chemotherapy. Ongoing research aims to understand the mechanisms behind these interactions and how modifying the microbiome could enhance cancer treatment. Probiotics, prebiotics, and fecal microbiota transplants are being explored as potential strategies to optimize the microbiome for better cancer outcomes.
